14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -3.273 3 days ( 8.94 % )
Last Price $0.272 -3.72 %
High/ Low $0.270 - $0.310 -17.41%
Chg 7 Days -26.49 % $0.370 $0.272
Chg 30 Days -19.24 % $0.337 $0.272
Chg 12 mos -78.06 % $1.24 $0.272
Trend - 3 mos 25.31 % Width: 86.35 %
Trend - 12 mos -75.78 % Width: 1,482.27 %
Pred. range - 3 mos $0.328 - $0.611 20.54 % - 124.63 %
Pred. range - 12 mos $0.0057 - $0.0908 -97.89 % - -66.63 %
Short MA avg 3 mos Sell Apr 24, 2024 - 8 days
Long MA avg 3 mos Sell Apr 30, 2024 - 4 days
Short/Long MA avg 3 mos Sell May 02, 2024 - 2 days
Short MA avg 12 mos Sell Apr 26, 2024 - 6 days
Long MA avg 12 mos Sell Apr 30, 2024 - 4 days
Short/Long MA avg 12 mos Buy Apr 19, 2024 - 11 days
Pivot Short Sell Apr 09, 2024 - 19 days
Bollinger Buy Jan 08, 2024 - 82 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Kazia Therapeutics Limited

Kazia Therapeutics Limited Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. It is also developing EVT801, an investigational new drug for various forms of cancer. The company was formerly known as Novogen Limited and changed its name to Kazia Thera... KZIA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT